|
Tuesday,
April 13, 2010
“Molecular Pathology in the
Age of Personalized Medicine”
Wayne W. Grody, M.D., Ph.D.
Director, Diagnostic Molecular Pathology Laboratory
UCLA School of Medicine
|
|
Objectives of Program:
- 1. To become aware of the latest genomic discoveries and
technological innovations that are driving the field of diagnostic
molecular pathology toward companion diagnostics and personalized
medicine.
- To consider the clinical utility of new molecular markers in
various cancers, genetic diseases, and pharmacogenetic applications.
- To become aware of the unique ethical, legal, psychosocial,
regulatory and economic implications surrounding these developments,
and their impact on patient access to "personalized medicine"
offered by this powerful diagnostic and predictive technology.
- Provide program participants with challenging and interesting
cases of use in everyday pathology practice.
IDENTIFIED NEED:
Identified by membership as valuable for its
provision of information in the field of Pathology.
The Los Angeles Society of Pathologists, Inc. is accredited by the
Institute for Medical Quality and the California Medical Association to
provide continuing medical education for physicians. The Los Angeles
Society of Pathologists, Inc. takes responsibility for the content,
quality and scientific integrity of this CME activity.
The Los Angeles Society of Pathologists, Inc. designates this
educational activity for a maximum of 1.5 AMA PRA Credit(s)TM.
Physicians should only claim credit commensurate with the extent of
their participation in the activity. This credit may also be applied to
the CMA Certification in Continuing Medical Education.
|